Breaking News Instant updates and real-time market news.

SYRS

Syros Pharmaceuticals

$10.06

-0.135 (-1.32%)

07:36
08/07/18
08/07
07:36
08/07/18
07:36

Syros Pharmaceuticals reports Q2 EPS (43c), consensus (50c)

Reports Q2 revenue $375,000, consensus $800,000. Cash, cash equivalents and marketable securities as of June 30 were $124.4M, compared with $72M on December 31, 2017.

  • 07

    Aug

  • 14

    Aug

SYRS Syros Pharmaceuticals
$10.06

-0.135 (-1.32%)

10/23/17
ROTH
10/23/17
INITIATION
Target $15
ROTH
Neutral
Syros Pharmaceuticals initiated with a Neutral at Roth Capital
Roth Capital analyst Jotin Marango started Syros Pharmaceuticals with a Neutral rating and $15 price target saying it is maturing into a solid company, but value-driving proof-of-concept may take a little longer.
10/31/17
PIPR
10/31/17
INITIATION
Target $30
PIPR
Overweight
Syros Pharmaceuticals assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff assumed coverage of Syros Pharmaceuticals with an Overweight rating and raised his price target for the shares to $30 from $20. The analyst sees the company creating value by expanding its clinical pipeline and signing new partnerships.
11/01/17
PIPR
11/01/17
NO CHANGE
PIPR
Overweight
Syros trading lower on lack of data, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff attributes the pullback today in shares of Syros Pharmaceuticals to the lack of clinical data in the online abstract, but the analyst notes this is just a placeholder. Syros will report Phase II data on SY-1425 monotherapy in biomarker-selected relapsed/refractory Acute Myeloid Leukemia and higher-risk Myelodysplastic Syndromes patients, as well as lower-risk, transfusion-dependent MDS patients in a poster at the American Society of Hematology meeting on December 10, Tenthoff tells investors in a research note. He reiterates an Overweight rating on the shares with a $30 price target.
07/17/18
PIPR
07/17/18
NO CHANGE
Target $28
PIPR
Overweight
Piper reiterates Overweight on Syros after call with oncologists
After hosting a call with two hematologic oncologists to highlight the unmet need to treat myelodysplastic syndromes and acute myeloid leukemia, Piper Jaffray analyst Edward Tenthoff reiterates an Overweight rating on shares of Syros Pharmaceuticals with a $28 price target. The analyst notes the company is conducting a Phase II study for SY-1425 in combination with azacitidine or anti-CD38 antibody Darzalex to treat intermediate to high-risk MDS or AML patients with data likely in Q4. Tenthoff remains confident in Syros' combination strategies in the ongoing study.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$272.86

0.27 (0.10%)

, SPX

S&P 500

$0.00

(0.00%)

10:36
11/13/18
11/13
10:36
11/13/18
10:36
Periodicals
Trump considering replacements for chief of staff, DHS secretary, ABC News says »

President Donald Trump is…

SPY

SPDR S&P 500 ETF Trust

$272.86

0.27 (0.10%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$43.97

-0.66 (-1.48%)

, SWI

SolarWinds

$14.94

0.19 (1.29%)

10:35
11/13/18
11/13
10:35
11/13/18
10:35
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

AERI

Aerie Pharmaceuticals

$43.97

-0.66 (-1.48%)

SWI

SolarWinds

$14.94

0.19 (1.29%)

PHAS

PhaseBio

$5.03

(0.00%)

LOGC

LogicBio Therapeutics

$13.87

(0.00%)

CREE

Cree

$42.80

1.27 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 26

    Nov

  • 14

    Mar

LITE

Lumentum

$40.92

3.415 (9.11%)

, BBY

Best Buy

$67.28

0.14 (0.21%)

10:35
11/13/18
11/13
10:35
11/13/18
10:35
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

LITE

Lumentum

$40.92

3.415 (9.11%)

BBY

Best Buy

$67.28

0.14 (0.21%)

PRGO

Perrigo

$65.43

-0.11 (-0.17%)

SBRA

Sabra Health Care

$20.84

-0.28 (-1.33%)

INFN

Infinera

$4.40

-0.15 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VERI

Veritone

$6.78

-0.11 (-1.60%)

, NVDA

Nvidia

$196.71

7.34 (3.88%)

10:35
11/13/18
11/13
10:35
11/13/18
10:35
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

VERI

Veritone

$6.78

-0.11 (-1.60%)

NVDA

Nvidia

$196.71

7.34 (3.88%)

XLNX

Xilinx

$84.02

1.69 (2.05%)

KOP

Koppers Holdings

$21.08

0.88 (4.36%)

SWN

Southwestern Energy

$6.08

0.28 (4.83%)

SAIL

SailPoint

$25.16

0.86 (3.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 20

    Nov

  • 26

    Nov

  • 26

    Nov

  • 27

    Nov

  • 10

    Dec

  • 09

    Jan

10:35
11/13/18
11/13
10:35
11/13/18
10:35
General news
Treasury Action: yields remained pinned lower »

Treasury Action: yields…

10:35
11/13/18
11/13
10:35
11/13/18
10:35
General news
U.S. Retail Sales Face Upside Risks in October: »

U.S. Retail Sales Face…

CBTX

CBTX

$33.14

(0.00%)

10:33
11/13/18
11/13
10:33
11/13/18
10:33
Conference/Events
CBTX management to meet with Stephens »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

XBI

SPDR S&P BIOTECH

$78.80

1.13 (1.45%)

10:30
11/13/18
11/13
10:30
11/13/18
10:30
Options
Second day of big spreads in SPDR Biotech ETF »

Second day of big spreads…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEP

Korea Electric Power

$12.00

0.06 (0.50%)

10:29
11/13/18
11/13
10:29
11/13/18
10:29
Upgrade
Korea Electric Power rating change  »

Korea Electric Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$109.48

0.44 (0.40%)

, SIG

Signet Jewelers

$56.30

0.96 (1.73%)

10:27
11/13/18
11/13
10:27
11/13/18
10:27
Periodicals
Alrosa said to cut low-end diamond prices by as much as 10%, Bloomberg reports »

Retail jewelers that may…

TIF

Tiffany

$109.48

0.44 (0.40%)

SIG

Signet Jewelers

$56.30

0.96 (1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

TSLA

Tesla

$337.76

6.61 (2.00%)

10:24
11/13/18
11/13
10:24
11/13/18
10:24
Periodicals
Tesla loses legal executive with regulatory experience, Bloomberg reports »

Phil Rothenberg, an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 13

    Dec

SRCL

Stericycle

$47.11

0.07 (0.15%)

10:23
11/13/18
11/13
10:23
11/13/18
10:23
Recommendations
Stericycle analyst commentary  »

Stericycle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$177.04

-2.47 (-1.38%)

10:21
11/13/18
11/13
10:21
11/13/18
10:21
Technical Analysis
Technical Take: Home Depot falls after earnings news »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ROST

Ross Stores

$100.34

-1.42 (-1.40%)

10:20
11/13/18
11/13
10:20
11/13/18
10:20
Options
Earnings hedge in Ross Stores »

Earnings hedge in Ross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

10:20
11/13/18
11/13
10:20
11/13/18
10:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

HD

Home Depot

$177.27

-2.24 (-1.25%)

10:19
11/13/18
11/13
10:19
11/13/18
10:19
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

T

AT&T

$30.85

0.05 (0.16%)

10:19
11/13/18
11/13
10:19
11/13/18
10:19
OnTheFly
Trump Effect: CNN suing White House over Jim Acosta’s revoked press credentials »

CNN has announced via…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$194.00

4.63 (2.44%)

10:18
11/13/18
11/13
10:18
11/13/18
10:18
Technical Analysis
Technical Take: Nvidia bounces off lows »

The shares hit an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

  • 10

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/13/18
11/13
10:17
11/13/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAG

Amag Pharmaceuticals

$18.04

0.07 (0.39%)

10:16
11/13/18
11/13
10:16
11/13/18
10:16
Recommendations
Amag Pharmaceuticals analyst commentary  »

Piper remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

  • 23

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/13/18
11/13
10:16
11/13/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAG

Amag Pharmaceuticals

$18.04

0.07 (0.39%)

10:12
11/13/18
11/13
10:12
11/13/18
10:12
Hot Stocks
FDA asks Amag for additional Vyleesi data, January panel meeting on hold »

Amag Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

  • 23

    Mar

AAL

American Airlines

$37.72

0.85 (2.31%)

10:10
11/13/18
11/13
10:10
11/13/18
10:10
Options
American Airlines attracts short-term call buying as shares advance »

American Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
11/13/18
11/13
10:02
11/13/18
10:02
Conference/Events
Washington Association of Money Managers to hold a meeting »

Tapan Gandhi, Principal…

GEOS

Geospace

$14.58

(0.00%)

10:01
11/13/18
11/13
10:01
11/13/18
10:01
Hot Stocks
Geospace announces acquisition of OptoSeis fiber optic technology »

Geospace Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.